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Themechanisms of long-term depression (LTD) underlie various aspects of normal brain function. Therefore,
it is important to understand the signaling that underpins LTD. The study by Scholz et al. in this issue of
Neuron describes how BRAG2, mGluRs, and AMPARs come together to produce LTD through AMPAR inter-
nalization.Picture the scene: the London under-
ground—one of the world’s busiest
subway systems—at rush hour on a Friday
evening. As is probably the case in most
similar transport systems, entry into or
out of the underground is controlled by
electronic gates. At rush hour it takes
a LONG time to get the thousands and
thousands of commuters through the
limited numbers of gates. Wouldn’t it be
great if it were possible to increase rapidly
the number of gates when needed and
reduce the number of gates when not
needed? However, one cannot even
begin to imagine the mechanical, electri-
cal, and computer engineering and design
needed to make this possible. How would
the gates be brought into the station lobby
and how would they be removed? Where
would they be stored? Would the station
lobby have to increase and decrease in
size to accommodate these changes?
What multitude of different control mech-
anisms would need to be in place to
ensure that everything happened in a
controlled and regulated manner?Remarkably, however, the central
nervous system deals with a similar
problem at synaptic junctions. At most
synapses fast chemical transmission is
mediated by release of glutamate acting
on AMPA receptors. One of the most
impressive things about synapses is that
their strength can be increased and
decreased very rapidly, a property known
as synaptic plasticity. These changes can
last a long time, if required (LTP, long-
term potentiation; LTD, long-term depres-
sion). One of the most well-studied mech-
anisms responsible for synaptic plasticity
is alterations in the numbers of AMPA
receptors on the receiving neuron.
In many ways, this is akin to the problem
of the underground—in response to partic-
ular demands the synapse increases or
decreases the number of AMPA receptors,
thus providing almost instantaneously
greater or reduced capacity to cope with
the demands thrown at the synapse. The
mechanisms that control these changes
in synaptic strength are turning out to be
hugely complex and are subject to a levelof fine tuning that could not have been
imagined even a few short years ago.
Currently, there is pretty good con-
sensus concerning the processes that
initiate or trigger synaptic plasticity, gener-
ally a rise in intracellular calcium resulting
from activation of particular classes of
receptors (e.g., NMDA or mGluRs). We
are also fairly confident that insertion or
removal of AMPARs at the synapse is
one of the key final steps that bring about
the change in synaptic strength. However,
the details of the precise mechanisms
between the initial trigger and the final
insertion or removal of AMPARs is still
the subject of intense investigation and
evidence exists for a variety of different
intracellular processes that are likely to
be involved in some way. Every so often
in the investigation of such mechanisms,
an exciting, new, and controversial
discovery is put forward, such as in this
issue of Neuron, in which Scholz et al.
(2010) describe a novel signaling mecha-
nism that controls the removal of synaptic
AMPARs, thereby controlling LTD.66, June 10, 2010 ª2010 Elsevier Inc. 627
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PreviewsThere is a great deal of evidence
that LTD induced by NMDAR activa-
tion requires serine/threonine phos-
phatases that dephosphorylate cer-
tain target proteins. The removal of
AMPARs is brought about by dyna-
min- and clathrin-mediated endocy-
tosis which in turn relies on interac-
tions between intracellular proteins
(e.g., AP2, PICK1, GRIP) and specific
regions of the C terminus of the
GluA2 subunit of AMPARs. How
dephosphorylation regulates the inter-
action between the GluA2 C terminus
and intracellular proteins and how
this regulates endocytosis is still very
uncertain.
In addition to the well-established
role of serine/threonine phosphatases
there has been increasing evidence
that LTD may rely on a protein tyrosine
phosphatase (PTP). Pharmacological
activation of group I mGluRs by the
agonist DHPG results in the induction
of robust LTD that is blocked by PTP
inhibitors but not by serine/threonine
phosphatase inhibitors (for review
see Gladding et al., 2009; Lu¨scher
and Huber, 2010). In addition, LTD is
associated with tyrosine dephosphor-
ylation of the GluA2 subunit and the
trafficking of AMPARs that underlies
LTD is blocked by PTP inhibitors
(Huang and Hsu, 2006; Moult et al.,
2006). Activity-dependent LTD that is
mGluR-dependent is also shown to rely
on PTP activity (Moult et al., 2008). Thus,
evidence is accumulating that tyrosine
dephosphorylation is important in
mGluR-LTD and other mGluR functions
(e.g., regulation of the slow afterhyperpo-
larization) may also be PTP dependent
(Ireland et al., 2004).
In the paper by Scholz et al. (2010), new
evidence is provided that shows how
tyrosine dephosphorylation may trigger
LTD. This requires a signaling cascade
based around a protein called BRAG2,
a guanine nucleotide exchange factor
for the plasma membrane GTPase Arf6.
Arf6 can recruit AP2 to synaptic
membranes, but no role for BRAG2 has
been identified in the brain. In the current
work, Scholz et al. (2010) carry out a very
comprehensive and detailed study of
the interactions between BRAG2 and
AMPARs. They show that BRAG2 inter-
acts with the tyrosine-rich sequence in
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sine 876 residue is critical for this interac-
tion. They further demonstrate that
BRAG2 colocalizes with synaptophysin,
suggesting its presence at the synapse,
and they show that it is highly concen-
trated in the PSD. So, what is the conse-
quence of the interaction between
BRAG2 and GluA2? Scholz et al. (2010)
show that binding of GluA2-BRAG2
causes an increase in BRAG2 catalytic
activity on Arf6. Next, they demonstrate
that the increased BRAG2 catalytic
activity upon binding GluA2 relies on the
phosphorylation state of Y876; when de-
phosphorylated there was an increase in
BRAG2 activity, but when phosphory-
lated there was no such increase. Thus,
the phosphorylation state of Y876
controls BRAG2-mediated GDP/GTP ex-
change on Arf6 (see Figure 1).
As mentioned above, mGluR-LTD has
been shown consistently to rely on tyro-
sine dephosphorylation, and Scholz
et al. (2010) demonstrate that Y876 isr Inc.the specific residue on GluA2 that is
dephosphorylated. In addition,
mGluR-LTD was associated with in-
creased activity of Arf6, and this
increase in Arf6 activity was prevented
by PTP inhibitors that also prevent
mGluR-LTD. This suggests a mecha-
nism by which mGluR stimulation trig-
gers a PTP that dephosphorylates
Y876 on GluA2; this allows an increase
in BRAG2 activation of Arf6, which in
turn regulates endocytosis. If this
were the case, then the decrease in
surface AMPARs and mGluR-LTD
should be blocked by preventing
BRAG2 function. Indeed, RNAi knock-
down of BRAG2 prevented DHPG-
induced reduction in surface GluA2,
but also importantly this knockdown
in hippocampal slices resulted in
a block of DHPG LTD in RNAi-infected
neurons. Furthermore, DHPG-LTD
was absent in neurons with Cre-medi-
ated deletion of BRAG2 but was
normal in noninfected neurons.
The data in this manuscript up to
this point are interesting since they
provide a link between tyrosine
dephosphorylation, BRAG2—a pro-
tein that previously had no known
role in brain—and a reduction of
surface AMPARs. Significantly, how-
ever, this work goes much further
and suggests that activation of the
AMPAR itself is critical in controlling
these signaling cascades and therefore
controlling the induction of LTD (see
Figure 1). First, the authors demonstrate
that glutamate stimulation of HEK cells
coexpressing GluA2, BRAG2, and Arf6
results in increased Arf6 activity, leading
to the suggestion that glutamate binding
to AMPARs may be critical for LTD. To
examine this further, two independent
pathways were stimulated in hippo-
campal slices and DHPG was applied to
induce LTD. However, stimulation in one
pathway was stopped during DHPG
application. In this pathway, no LTD
was observed whereas normal LTD was
observed in the other pathway. Further-
more, blocking AMPARs with kynurenic
acid prevented induction of DHPG-LTD.
Therefore, under these conditions ligand
binding to AMPARs is critical for
mGluR-LTD.
This finding is likely to be somewhat
controversial given that there is published
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Figure 2. Consequences of the Requirement of Both AMPAR and
mGluR Activation for LTD Induction
(A) At a weakly active synapse AMPARs, but not perisynaptic group I mGluRs,
are stimulated by glutamate and LTD is not induced.
(B) When a synapse is strongly activated both AMPARs and mGluRs are stim-
ulated and LTD occurs.
(C) Glutamate spillover can activate perisynaptic mGluRs. If glutamate spills
over from a strongly activated synapse (middle), then LTD will occur at this
synapse. However, LTD will also occur at a neighboring synapse that is
concurrently only weakly active since both mGluR and AMPARs are stimulated
(right). LTD will not be induced at a neighboring inactive synapse as only
mGluR but not AMPAR stimulation will occur at this synapse (left).
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Previewswork that directly contradicts
these results. Two studies
have previously shown that
DHPG-LTD is induced in
hippocampus in the absence
of synaptic stimulation
(Fitzjohn et al., 1999; Huber
et al., 2001), and Fitzjohn
et al. (2001) showed that
DHPG-LTD is induced in zero
external calcium, i.e., in the
absence of synaptic transmis-
sion. Both of these findings
clearly show that AMPAR acti-
vation is not required for LTD.
In addition, other forms of
LTD (e.g., induced by carba-
chol) also do not require
synaptic stimulation (Massey
et al., 2001). This raises the
question: under what condi-
tions is there a requirement
for AMPAR stimulation in
mGluR-LTD? Some work that
may provide a clue was pub-
lished by Kemp and Bashir
(1999), which indicated that
synaptically induced LTD
required activation of AMPA
and mGluRs. Another questionthat remains unanswered is ‘‘how exactly
does AMPAR activation contribute to this
form of LTD?’’ It is possible that ligand
binding causes a conformational change
to the GluA2 subunit that allows better
access for Y876 dephosphorylation and
BRAG2 binding, but this remains to be
proved.
Interestingly, Scholz et al. (2010) show
that inhibitors of src family tyrosine
kinases can by themselves lead to
dephosphorylation of Y876 and activation
of Arf6. If AMPAR activation itself causes
increased Arf6 activity, and if inhibition of
src family tyrosine kinases can also lead
to Arf6 activation, one question is ‘‘why
do simple AMPAR activation or tyrosine
kinase inhibition alone not lead to AMPAR
internalization and LTD?’’ The study by
Moult et al. (2008) provides an answer to
this question. They showed that mGluR-
LTD required not just activation of a PTP,
but also activation of another parallel path-
way involving p38 MAPK. Activation of
just one of these pathways is not sufficient
to induce LTD. Hence, although AMPAR
activity or tyrosine kinase inhibition will
lead to GluA2 Y876 dephosphorylation,LTD does not occur as the MAPK is not
also activated.
Another issue that needs to be resolved
regarding tyrosine phosphorylation state
and LTD is that AMPAR internalization by
insulin relies on tyrosine phosphorylation
(Ahmadian et al., 2004) rather than dephos-
phorylation of the C terminus of GluA2.
This study also raises questions about
NMDA-LTD, as it is shown that NMDA-
LTD is also dependent on BRAG2.
However, given that NMDA-LTD does
not rely on PTP activity and given that
the present study shows that PTP activity
is essential for the increase in BRAG2
activation of Arf2, the relationship
between BRAG2 and NMDA-LTD still
remains to be determined.
The results of this study raise some
intriguing new concepts related to poten-
tial mechanisms of LTD. Why would a
system develop whereby cooperative
activation of both mGluRs and AMPARs
is required to produce AMPAR internaliza-
tion and LTD? There may be many
different possible explanations, but
some possible scenarios are described
here and illustrated in Figure 2:Neuron 66, June 101. A weakly active
synapse will only stimu-
late AMPARs but not
group I mGluRs, which
are located perisynapti-
cally, which will prevent
LTD from occurring
under basal conditions
(Figure 2A).
2. When a synapse is
strongly active, gluta-
mate release will stimu-
late both synaptic
AMPARs and perisynap-
tic group I mGluRs.
Therefore, under these
conditions LTD can
occur (Figure 2B). This
is consistent with the
observations that stim-
ulus-induced mGluR-
LTD relies on strong
induction protocols
(Kemp and Bashir 1999;
Huber et al., 2000).
Since group I mGluRs are peri-
synaptic, they are more likely
to be activated by glutamate
spillover from neighboringstrongly active synapses. This has two
further possible consequences:
3. Activation of perisynaptic group I
mGluRs by glutamate spillover at an
otherwise inactive synapse will not
result in LTD since there is no activa-
tion of AMPARs (Figure 2C). So a
mechanism whereby both receptors
need to be activated may prevent
the LTD mechanism from being inad-
vertently stimulated by spillover, and
thus LTD is kept synapse specific;
only those synapses where group I
mGluRs and AMPARs are activated
will undergo LTD.
4. In contrast, synaptic glutamate
release at a weakly active synapse
may result in activation of AMPARs.
In this case, spillover of glutamate
from strongly active neighboring
synapses may activate group I
mGluRs at the weakly active syn-
apse and result in LTD (Figure 2C).
This induction of LTD brought about
by glutamate release from neigh-
boring synapses provides a mecha-
nism of cooperative plasticity., 2010 ª2010 Elsevier Inc. 629
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PreviewsThe study of both LTP and LTD has
uncovered a plethora of different signaling
cascades that regulate AMPAR surface
expression. The work of Scholz et al.
(2010) describes some exciting, novel
and controversial findings that provide
a greater understanding of the regulation
of synaptic AMPARs and LTD—now that’s
something to BRAG about.REFERENCES
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